Mizuho Sees Improved Regulatory Stability, Raises Cigna (CI) Price Objective

With a TTM operating cash flow of $8.81 billion, The Cigna Group (NYSE:CI) is included among the 12 Cash-Rich Stocks to Buy Right Now.

On June 8, Mizuho raised the firm’s price recommendation on The Cigna Group (NYSE:CI) to $340 from $330. It reiterated an Outperform rating on the shares. Analyst Ann Hynes said Mizuho believes the managed care sector is moving into a “more stable and predictable” policy environment. According to the firm, policy-related surprises are likely to become less frequent and less severe than they have been over the past three years. That shift could allow investors to focus more on company fundamentals, pricing recovery, and the sector’s underlying earnings potential. Mizuho also increased price targets across the managed care sector to reflect what it sees as a more stable regulatory and legislative backdrop.

On May 22, UBS raised its price goal on Cigna to $400 from $375. It maintained a Buy rating on the stock. In a research note, the analyst said managed care companies generally raised their guidance after stronger-than-expected first-quarter results. Performance benefited from favorable respiratory trends and seasonal cost patterns. The firm also pointed to improved Medicare Advantage rates, more stable ACA exchange enrollment, and modest outperformance in Medicaid as factors that have increased confidence in margin recovery. At the same time, UBS noted that companies continue to face cost pressures from specialty drugs, GLP-1 treatments, and behavioral health services.

The Cigna Group (NYSE:CI) is a global health company that operates through two business segments: Evernorth Health Services and Cigna Healthcare.

READ NEXT: 10 Most Profitable Dividend Stocks to Invest In Now and 10 Best Dividend Stocks to Buy According to D. E. Shaw

Disclosure: None. Follow Insider Monkey on Google News.